By AdminM
by Paul Fassa
Health Impact News
The largest, most expensive antidepressant efficacy study involving over 4,000 initial participants ended in 2006. The purported intention of the study was to provide real-life results instead of the shorter clinical trial results that are done to get antidepressant drugs approved.
But the results were not clear regarding antidepressants’ true efficacy compared to clinical trials. Safety was not a consideration, just efficacy at reducing depression.
A new study has recently re-analyzed this massive STAR*D (Sequenced Treatment Alternatives to Relieve Depression) study funded by the National Institute of Mental Health …read more
Source: Health Impact News
- Rating:
- Views:143 views
- Categories: Health
Thanks! Share it with your friends!
Tweet
Share
Pin It
LinkedIn
Google+
Reddit
Tumblr